Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Huaxin Pharmaceutical Group specializes in the development, manufacturing, and distribution of pharmaceutical preparations including both chemical drugs/APIs/intermediates as well as traditional Chinese medicines. The company has established R&D centers and industrial bases across China. Its portfolio covers a wide range of therapeutic areas with a particular emphasis on anti-tumor agents, anti-infectives, hypoglycemics, respiratory diseases, cardiovascular conditions, digestive health products, dermatology treatments and sedative/tranquilizer formulations. It operates at commercial scale with GMP-compliant facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Huaxin Pharmaceutical Group.